Taxus Cardium Pharmaceuticals Group Inc (CRXM)

[RyNo_23]

https://s3.amazonaws.com/sec.irpass.cc/2452/0001493152-21-005117.htm

SCHEDULE 13D

Item 4. Purpose of Transaction.



Mr. Jemapete purchased an aggregate of 3,500,000 of the issuer’s common stock in a series of transactions effected between February 11, 2021 and February 26, 2021 via open market purchases. These securities were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.



Item 5. Interest in Securities of the Issuer.



(a) 3,500,000 shares, or approximately 24.2% (based on 14,489,399 shares of the issuer’s common stock issued and outstanding as of May 22, 2020, as reported on the issuer’s Current Report on Form 8-K filed with the Securities and Exchange Commission on May 28, 2020.



(b) Sole voting power: 3,500,000 shares
Shared voting power: 0 shares
Sole dispositive power: 3,500,000 shares
Shared dispositive power: 0 shares


(c) The reporting person effected open market purchases of the following shares of the issuer’s common stock during the past 60 days:



Date Aggregate No. of Shares Purchased Average Price Per Share
February 11, 2021 100,000 $ 0.0496
February 12, 2021 100,000 $ 0.0494
February 16, 2021 100,000 $ 0.0400
February 19, 2021 57,000 $ 0.0350
February 22, 2021 43,000 $ 0.0350
February 24, 2021 300,000 $ 0.0436
February 25, 2021 1,205,000 $ 0.0433
February 26, 2021 1,595,000 $ 0.0480